<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-NAME ACODE="10800">증권발행실적보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20220117">2.6</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01263527">(주)카이노스메드</COMPANY-NAME>


<BODY>

<LIBRARY>
<CORRECTION>
<TITLE ATOC="Y" AASSOCNOTE="CORRECTION">정 정 신 고 (보고)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">2022년 09월 16일</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P USERMARK="F-14">1. 정정대상 공시서류 : 증권발행실적보고서</P>
<P></P>
<P USERMARK="F-14">2. 정정대상 공시서류의 최초제출일 : 2022년 09월 16일</P>
<P></P>
<P USERMARK="F-14">3. 정정사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">Ⅲ. 유상증자 전후의 주요주주 지분변동</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">오기 정정</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" B">(주1) 정정 전</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" B">(주1) 정정 후</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(주1) 정정 전</SPAN>
</P>
<P USERMARK="F-16 0XFF0000 B">Ⅲ. 유상증자 전후의 주요주주 지분변동</P>
<P></P>
<P></P>

<TABLE WIDTH="617" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 전</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 후</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기섭</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,154,525</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.13</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  3,268,528</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.71</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이애주</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,114,241</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.99</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,234,259</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.42</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최인석</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,078,927</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.83</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,386,399</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.97</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이건환</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">553,063</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.48</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    593,945</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미란</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.31</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미숙</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.28</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">BRIANA BOHAE LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">MIRIAM B LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이광호</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,620</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.12</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      27,620</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이원영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,669</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.07</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      14,669</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이태길</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,138</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.06</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      13,138</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이재문</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">등기임원</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,588</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.09</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      20,588</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기세</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,469</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.02</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       4,469</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이미경</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,589</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       2,589</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최광재</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신용일</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김은희</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배종덕</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">고수영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,198,686</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27.76</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,781,061</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24.29</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 증자 전 발행주식총수 : 22,322,396주주2) 증자 후 발행주식총수 : 27,922,396주</P>

<P>
<SPAN USERMARK=" B">(주1) 정정 후</SPAN>
</P>
<P USERMARK="F-16 0XFF0000 B">Ⅲ. 유상증자 전후의 주요주주 지분변동</P>
<P></P>

<TABLE WIDTH="617" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 전</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 후</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기섭</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,040,525</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">13.62</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,154,528</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이애주</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">978,351</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">4.38</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1,098,369</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3.93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최인석</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">822,700</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3.69</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1,130,172</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">4.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이건환</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">512,181</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2.29</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">553,063</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1.98</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미란</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.31</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미숙</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.28</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">BRIANA BOHAE LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">MIRIAM B LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이광호</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22,080</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.10</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22,080</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이원영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11,727</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11,727</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이태길</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">10,503</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">10,503</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이재문</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">등기임원</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">17,387</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.08</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">20,726</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기세</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,573</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.02</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,573</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이미경</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2,070</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2,070</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최광재</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신용일</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김은희</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배종덕</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">고수영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">5,635,954</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">25.25</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">6,221,668</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22.28</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 증자 전 발행주식총수 : 22,322,396주주2) 증자 후 발행주식총수 : 27,922,396주</P>
<PGBRK></PGBRK>
</CORRECTION>
</LIBRARY>


<COVER>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">증권발행실적보고서</COVER-TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="430"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" COLSPAN="2" WIDTH="600" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30">금융감독원장 귀하</TD>
<TD CLASS="NORMAL" ALIGN="RIGHT" WIDTH="439" HEIGHT="30">2022년   09월   16일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53">회       사       명 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53">주식회사 카이노스메드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53">대   표     이   사 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53">이기섭</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53">본  점  소  재  지 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53">경기도 성남시 분당구 대왕판교로 700, 코리아바이오파크 제3층 제에이-301호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(전  화)02-567-7419</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(홈페이지) http://www.kainosmedicine.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30">작  성  책  임  자 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(직  책) 대표이사               (성  명) 이기섭</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(전  화) 02-567-7419</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53"></TD>
</TR>
</TBODY>
</TABLE>
</COVER>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-1-0">Ⅰ. 발행개요</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 기업개요</TITLE>

<TABLE-GROUP ACLASS="CRP_OTLN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업규모</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">업종구분</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TU WIDTH="200" HEIGHT="30" AUNIT="CRP_RGS_CLS" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="2">코스닥</TU>
<TU WIDTH="200" HEIGHT="30" AUNIT="CRP_SCL" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="2">중소기업</TU>
<TU WIDTH="200" HEIGHT="30" AUNIT="CRP_CODE" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="70">연구개발업</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 발행 개요</TITLE>

<TABLE-GROUP ACLASS="PBL_OTLN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행총액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TU WIDTH="200" HEIGHT="53" AUNIT="DST_SMR" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="3">기타</TU>
<TE WIDTH="200" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" ACODE="INC_SL_PO_SUM">26,320,000,000</TE>
<TE WIDTH="200" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" ACODE="NOTE">주주배정 후 실권주 일반공모 유상증자</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-2-0">Ⅱ. 청약 및 배정에 관한 사항</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 청약 및 납입일정</TITLE>

<TABLE-GROUP ACLASS="SB_DT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약개시일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약종료일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">납입기일</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACODE="SB_CO">구주주 청약(초과청약 포함)</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SB_STR_DT" AUNITVALUE="20220905">2022년 09월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SB_END_DT" AUNITVALUE="20220906">2022년 09월 06일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="PYM_DT" AUNITVALUE="20220916">2022년 09월 16일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="SB_CO">일반공모</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="SB_STR_DT" AUNITVALUE="20220913">2022년 09월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="SB_END_DT" AUNITVALUE="20220914">2022년 09월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="PYM_DT" AUNITVALUE="20220916">2022년 09월 16일</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 인수기관별 인수금액</TITLE>

<TABLE-GROUP ACLASS="ACC_AMT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수기관</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비 율(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비  고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" ACODE="ACC_ORG">한양증권(주)</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACODE="ACC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ACC_AMT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACODE="ACC_RT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACODE="TOT_ACC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="TOT_ACC_AMT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACODE="TOT_ACC_RT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACODE="TOT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">3. 청약 및 배정현황</TITLE>

<TABLE-GROUP ACLASS="DST_CD" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="896" BORDER="0">

<COLGROUP>
<COL WIDTH="420"></COL>
<COL WIDTH="458"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="429" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" WIDTH="467" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="1">(단위 : 원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="982" BORDER="1">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="46"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초 배정</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="347" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약 현황</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="323" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최종 배정 현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">건수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">건수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="180" HEIGHT="30" ACODE="DST_CD">구주주(신주인수권증서)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">5,600,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="FST_DV_RT">100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">5,060</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SB_ST_CNT">4,625,522</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="SB_AMT">21,739,953,400</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SB_RT">3.78</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">5,060</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">4,625,522</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">21,739,953,400</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="DV_RT">82.60</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="180" HEIGHT="30" ACODE="DST_CD">구주주(초과청약)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="FST_DV_RT">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">3,999</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SB_ST_CNT">722,323</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="SB_AMT">3,394,918,100</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SB_RT">0.59</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">3,999</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">722,323</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">3,394,918,100</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="DV_RT">12.90</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="180" HEIGHT="30" ACODE="DST_CD">실권주 일반공모</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="FST_DV_RT">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">1,035</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SB_ST_CNT">117,009,465</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="SB_AMT">549,944,485,500</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SB_RT">95.63</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">1,023</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">252,155</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">1,185,128,500</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="DV_RT">4.50</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="180" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT_TOT">5,600,000</TE>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" AUPDATECONT="N">100</TD>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT_TOT">10,094</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SB_ST_CNT_TOT">122,357,310</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="SB_AMT_TOT">575,079,357,000</TE>
<TD ALIGN="RIGHT" WIDTH="55" HEIGHT="30" AUPDATECONT="N">100</TD>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT_TOT">10,082</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT_TOT">5,600,000</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT_TOT">26,320,000,000</TE>
<TD ALIGN="RIGHT" WIDTH="55" HEIGHT="30" AUPDATECONT="N">100</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">4. 일반투자자 배정방식별 배정현황</TITLE>

<TABLE-GROUP ACLASS="NOR_ASS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">배정수량(주)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">균등방식 유형</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">균등방식</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_RT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_TYP">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">비례방식</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="PRP_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="PRP_RT">-</TE>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="CNT_TOT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="RT_TOT">-</TE>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">5. 기관투자자 의무보유확약기간별 배정현황</TITLE>

<TABLE-GROUP ACLASS="INS_ASS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="804" BORDER="0">

<COLGROUP>
<COL WIDTH="393"></COL>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="402" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="402" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="804" BORDER="1">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">확약기간</TH>
<TH COLSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="410" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">국내 기관투자자</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="204" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">외국 기관투자자</TH>
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용사(집합)</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">투자매매ㆍ중개업자</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">연기금,운용사(고유)은행,보험</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기타</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">거래실적유</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">거래실적무</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="ASS_PRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_RT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" AUPDATECONT="N">미확약</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="NIN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="NIN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NTOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NTOT_RT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="TIN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="TIN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TTOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TTOT_RT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-3-0">Ⅲ. 유상증자 전후의 주요주주 지분변동</TITLE>
<P></P>
<P></P>

<TABLE WIDTH="617" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 전</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증자 후</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기섭</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,040,525</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">13.62</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,154,528</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이애주</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">978,351</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">4.38</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1,098,369</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3.93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최인석</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">822,700</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3.69</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1,130,172</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">4.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이건환</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동보유자</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">512,181</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2.29</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">553,063</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">1.98</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미란</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.31</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노미숙</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.28</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,380</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">BRIANA BOHAE LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,345</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">MIRIAM B LEE</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.14</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,336</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이광호</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22,080</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.10</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22,080</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이원영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11,727</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">11,727</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이태길</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">10,503</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">10,503</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이재문</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">등기임원</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">17,387</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.08</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">20,726</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이기세</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,573</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.02</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">3,573</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이미경</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2,070</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">2,070</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최광재</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,486</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신용일</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,024</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김은희</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,161</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배종덕</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">고수영</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,639</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">5,635,954</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">25.25</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">6,221,668</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">22.28</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 증자 전 발행주식총수 : 22,322,396주주2) 증자 후 발행주식총수 : 27,922,396주</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-4-0">Ⅳ. 증권교부일 등</TITLE>
<P>- 주권상장 및 유통 예정일 : 2022년 09월 28일(수)</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-5-0">Ⅴ. 공시 이행상황</TITLE>
<P></P>
<P>1. 공고의 일자 및 방법</P>

<TABLE ACLASS="NORMAL" WIDTH="663" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="284"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30" USERMARK=" BC0XD7D7D7">일 자</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="30" USERMARK=" BC0XD7D7D7">공고방법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="76">신주발행(신주배정기준일)의 공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="76">2022년 06월 10일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="76">회사 인터넷 홈페이지(www.kainosmedicine.com)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="53">(정정)신주발행(신주배정기준일)의 공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="53">2022년 06월 24일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="53">회사 인터넷 홈페이지(www.kainosmedicine.com)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="53">(정정)신주발행(신주배정기준일)의 공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="53">2022년 07월 07일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="53">회사 인터넷 홈페이지(www.kainosmedicine.com)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="53">모집 또는 매출가액 확정의 공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="53">2022년 09월 01일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="53">회사 인터넷 홈페이지(www.kainosmedicine.com)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="99">실권주 일반공모 청약공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="99">2022년 09월 07일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="99">회사 인터넷 홈페이지(www.kainosmedicine.com)한양증권(주) 홈페이지(www.hygood.co.kr)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="53">실권주 일반공모 배정공고</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="53">2022년 09월 16일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="53">한양증권(주) 홈페이지(www.hygood.co.kr)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>2. 증권신고서가. 전자문서 : 금융위(금감원) 전자공시시스템 →  http://dart.fss.or.kr나. 증권신고서 제출일 :</P>

<TABLE WIDTH="659" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="650"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="659" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[증권신고서 제출 및 정정 연혁]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="659" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="260"></COL>
<COL WIDTH="244"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제출일자</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">문서명</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 06월 10일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 06월 24일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 07월 05일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 07월 07일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 07월 20일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 07월 22일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[발행조건확정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1차 발행가액 확정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 08월 17일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">반기보고서 제출에 따른 기재정정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 01일</TD>
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[발행조건확정]증권신고서(지분증권)</TD>
<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최종 발행가액 확정</TD>
</TR>
</TBODY>
</TABLE>
<P>3. 투자설명서가. 전자문서 : 금융위(금감원) 전자공시시스템 →  http://dart.fss.or.kr나. 서면문서 : (주)카이노스메드 → 경기도 성남시 분당구 대왕판교로 700 코리아바이오파크 제3층 제에이-301호 일부한양증권(주) → 서울특별시 영등포구 국제금융로6길 7 </P>
<P>다. 투자설명서 제출일 : </P>

<TABLE WIDTH="832" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="823"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="832" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[투자설명서 제출 및 정정 연혁]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="832" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="497"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제출일자</TD>
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">문서명</TD>
<TD WIDTH="506" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 07월 22일</TD>
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">투자설명서</TD>
<TD WIDTH="506" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 01일</TD>
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]투자설명서</TD>
<TD WIDTH="506" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">반기보고서 제출에 따른 기재정정 및 최종 발행가액 확정에 따른 정정</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-6-0">Ⅵ. 조달된 자금의 사용내역</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 자금조달 내용</TITLE>

<TABLE-GROUP ACLASS="INC_SL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="283"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="292" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식구분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">신고서상발행예정총액</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="283" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">실제 조달금액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">발행가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">수 량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">발행총액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" AUPDATECONT="N">모집</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_RPT_MN">26,320,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="INC_STK_AMT">4,700</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="INC_STK_CNT">5,600,000</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_STK_TOT">26,320,000,000</TE>
<TE WIDTH="87" HEIGHT="30" ACODE="INC_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_RPT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="INC_AMT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="INC_CNT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_TOT">-</TE>
<TE WIDTH="87" HEIGHT="30" ACODE="INC_NOTE_TOT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" AUPDATECONT="N">매출</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SL_STK_KND">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SL_RPT_MN">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SL_STK_AMT">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SL_STK_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SL_STK_TOT">-</TE>
<TE WIDTH="87" HEIGHT="30" ACODE="SL_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SL_RPT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SL_AMT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SL_CNT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SL_TOT">-</TE>
<TE WIDTH="87" HEIGHT="30" ACODE="SL_NOTE_TOT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" AUPDATECONT="N">총  계</TD>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_SL_RPT_SUM">26,320,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="INC_SL_AMT_SUM">4,700</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="INC_SL_CNT_SUM">5,600,000</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="INC_SL_SUM">26,320,000,000</TE>
<TE WIDTH="87" HEIGHT="30" ACODE="TOT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 자금의 사용목적</TITLE>

<TABLE-GROUP ACLASS="INC_PRPS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="697" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="388"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="397" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="704" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">시설자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">영업양수자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">운영자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">채무상환자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">타법인증권취득자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기타</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="78" HEIGHT="30" ACODE="FND_USE1" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="78" HEIGHT="30" ACODE="FND_USE_SQ" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="113" HEIGHT="30" ACODE="FND_USE2" VALIGN="MIDDLE" ALIGN="RIGHT">8,856,000,000</TE>
<TE WIDTH="121" HEIGHT="30" ACODE="FND_USE5" VALIGN="MIDDLE" ALIGN="RIGHT">17,000,000,000</TE>
<TE WIDTH="93" HEIGHT="30" ACODE="FND_USE_AS" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="100" HEIGHT="30" ACODE="FND_USE4" VALIGN="MIDDLE" ALIGN="RIGHT">464,000,000</TE>
<TE WIDTH="121" HEIGHT="30" ACODE="FND_USE_SUM" VALIGN="MIDDLE" ALIGN="RIGHT">26,320,000,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>가. 공모자금 세부 사용목적 당사는 금번 유상증자로 조달된 자금을 현재 연구 중인 파이프라인 중 KM-819의 미국 임상 2상 및 국내 임상 2상의 임상시험비용, 추가적인 임상 진입을 위한 R&D비용 및 연구개발비용, 제2회 전환사채 채무상환자금 등으로 사용할 예정입니다. 만약 금번 유상증자의 공모금액이 당초 계획한 금액에 미달할 경우 당사는 아래에 표기한 자금사용계획 우선순위에 따라 집행 시기를 고려하여 세부적으로 조정할 예정이며, 부족분 및 전환사채의 이자, 발행제비용은 당사의 자체자금으로 충당할 계획입니다. 금번 유상증자를 통한 공모자금의 세부 사용 내역은 아래와 같습니다.</P>

<TABLE WIDTH="663" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="654"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="663" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[유상증자 자금사용의 우선순위]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="663" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 백만원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="665" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="412"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>자금용도</P>
</TD>

<TD WIDTH="421" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>세부 내용</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>금액</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">채무상환자금</TD>
<TD WIDTH="421" HEIGHT="30">제2회 전환사채 상환자금</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>운영자금</P>
</TD>

<TD WIDTH="421" HEIGHT="30">
<P>임상시험비용(KM-819(파킨슨병), KM-819(다계통위축증))</P>
</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,830</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>운영자금</P>
</TD>

<TD WIDTH="421" HEIGHT="30">
<P>연구개발비용(R&D비용, FAF1-Exosome 항암제 개발)</P>
</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타자금</TD>
<TD WIDTH="421" HEIGHT="30">발행제비용</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">464</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="571" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,320</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1. 채무상환자금 : 제2회 전환사채 상환자금</P>
<P>당사는 2020년 06월 연구개발비 등 임상 시험을 진행 중인 자회사의 운영자금 및 당사 자체 운영자금을 조달하기 위해 20,000백만원 규모의 제2회 사모 전환사채를 발행하였으며, 신고서 제출 전일 기준 조기상환청구 및 전환청구 건수는 전무하여 현재 채권 잔액은 17,000백만원(전자등록총액 기준)입니다.제2회 전환사채의 전환가액은 시가하락에 의한 전환가격 조정 및 주식병합에 따른 전환가격 조정이 완료된 20,350원이며, 최근 주가대비 전환가액이 상회하는 외가격(OTM, Out of Money) 상태로 채권자들의 조기상환 청구 가능성이 높다고 판단됩니다.</P>

<TABLE WIDTH="965" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="956"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="965" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[전환사채 발행 개요]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="965" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="967" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="752"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="761" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">사채의 명칭</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">주식회사 카이노스메드 제2회 무기명식 이권부 무보증 사모 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">발행일</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">2020년 06월 30일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">만기일</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">2025년 06월 30일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">발행금액(전자등록총액 기준)</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">20,000백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">잔액(전자등록총액 기준)</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">17,000백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">상화방법</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">만기일에 원금의 105.1205%를 일시상환한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">사채의 이율</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">표면금리 0% (만기보장수익률은 3개월 단위 복리계산 1%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="53">조기상환청구권(Put Option)</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="53">사채권자는 사채의 발행일로부터 24개월 이후 45개월까지의 기간중 원금의 전부 및 일부에 대하여 조기상환수익률 연 1.0%(3개월 단위 복리계산)가 적용된 청구 금액을 조기상환 청구할 수 있음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="76">매도청구권(Call Option)</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="76">회사는 사채권자로부터 회사 또는 회사가 지정하는 제3자(매수인)에게사채의 발행일로부터 12개월 이후 24개월까지의 기간 중 매 3개월에 해당되는 날에 원금의 25/100에 대하여 매도 청구할 수 있음. 매수인이 매도청구 행사시 연1.0%(3개월 단위 복리계산)의 이율을 적용하여 계산한 금액을 지급하여야 함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">전환가격(주)</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">5,813원/주 (최초 발행당시 전환가격)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="30">전환기간</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="30">2021년 6월 30일부터 2025년 3월 30일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="99">전환가격의 조정</TD>
<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="99">발행회사가 시가를 하회하는 발행가액으로 유상증자, 무상증자, 주식배당 및 준비금의 자본전입 등으로 주식을 발행하는 경우, 시가를 하회하는 전환가액 또는 행사가액으로 전환사채 또는 신주인수권부사채를 발행하는 경우에는 전환가격이 조정될 수 있으며, 발행회사의 보통주식 주가가 하락할 경우 발행일로부터 매 3개월마다 약정에 따라 조정전 전환가격의 70%까지 전환가격 조정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="145">전환가격</TD>

<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="145">
<P>(1)최초 전환가액: 5,813원/주(2)1차 조정전환가액: 4,852원/주 (2020년 09월 30일 조정)</P>
<P>(3)2차 조정전환가액: 4,386원/주 (2020년 12월 30일 조정)</P>
<P>(4)3차 조정전환가액: 4,070원/주 (2021년 03월 30일 조정)(5)주식병합에 따른 조정전환가액: 20,350원/주 (2022년 07월 12일 조정)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" HEIGHT="122">최초 인수인</TD>

<TD WIDTH="761" VALIGN="MIDDLE" HEIGHT="122">
<P>(1)NH투자증권(파인밸류PreIPO플러스 전문투자형 사모증권투자신탁의  신탁업자지위에서) 5,000백만원(2)NH투자증권(파인밸류IPO플러스V 전문투자형 사모증권투자신탁의  신탁업자 지위에서) 5,000백만원(3)KB증권(파인밸류메자닌플러스 전문투자형 사모증권투자신탁[채권혼합]의  신탁업자 지위에서) 2,000백만원(4)KB증권(파인밸류PostIPO3호 전문투자형 사모증권투자신탁의  신탁업자 지위에서) 3,000백만원(5)㈜SC 유나이티드 5,000백만원</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="964" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="955"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="964" HEIGHT="30">출처) 당사 정기보고서 및 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[제2회 전환사채로 조달한 자금사용내역]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="471"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">항목</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" HEIGHT="53">타법인증권취득(미국 자회사 FAScinate Therapeutics, Inc.) - KM-819(파킨슨병 치료제)의 미국 임상 2상 진행을 위한 자금 조달</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">18,052</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" HEIGHT="30">R&D 운영비</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,542</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" HEIGHT="30">일반운영비</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" HEIGHT="30">발행제비용</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="480" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="595" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="586"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="595" HEIGHT="30">출처) 당사 정기보고서 및 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="538" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="529"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="538" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[제2회 전환사채 조기상환일 및 청구기간] </TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="541" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="2" WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>조기상환 청구기간</P>
</TD>

<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>조기상환지급일</P>
</TD>

<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>조기상환수익률</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>FROM</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>TO</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-05-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-05-31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-06-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>102.0176%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-08-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-08-31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-09-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>102.2726%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-10-31</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-11-30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022-12-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>102.5283%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>4차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-01-29</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-02-28</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-03-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>102.7846%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>5차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-05-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-05-31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-06-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>103.0416%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>6차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-08-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-08-31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-09-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>103.2992%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>7차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-10-31</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-11-30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023-12-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>103.5574%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>8차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-01-30</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-02-29</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-03-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>103.8163%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>9차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-05-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-05-31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-06-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>104.0759%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>10차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-08-01</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-09-02</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-09-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>104.3361%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>11차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-10-31</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-12-02</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2024-12-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>104.5969%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>12차</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2025-01-29</P>
</TD>

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2025-02-28</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2025-03-30</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">
<P>104.8584%</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="545" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="536"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="545" HEIGHT="30">출처) 2020.06.26 당사 주요사항보고서(전환사채발행결정)</TD>
</TR>
</TBODY>
</TABLE>
<P>제2회 전환사채의 전환가격은 20,350원은 최근 당사의 주가수준(증권신고서 제출 전일 종가 8,780원)에 비해 외가격(OTM, Out of Money) 상태에 있기 때문에 채권자들의 조기상환 청구가 이루어질 것으로 예상하고 있습니다. 제2회 전환사채 17,000백만원에 대하여 당사는 금번 유상증자를 통해 조달된 자금을 조기상환에 사용할 예정이며, 상환시 발생하는 이자는 자체자금을 활용하여 상환할 예정입니다. 금번 진행하는 유상증자가 완료되기 전에 조기상환 청구가 이루어질 경우 선제적으로 당사의 자체자금으로 상환할 예정입니다. </P>
<P>2. 운영자금 : 임상시험비용 </P>
<P>당사는 인간의 불치병, 난치병, 삶의 질 개선을 위한 혁신적인 신약을 연구하고 이를 적정 개발단계의 신약후보물질로 License-Out 함으로써 수익을 창출하는 것을 사업으로 영위하고 있습니다.당사가 현재 개발중인 프로젝트들을 타겟 시장(질환)별로 분류해보면 뇌질환(파킨슨병 치료제, 다계통위축증), 항바이러스(에이즈 치료제), 항암제(IRAK4, FAF1-exosome 등) 등으로 분류할 수 있으며, 당사는 현재 적절한 치료약물이 없는 질환들을 대상으로 합성의약 및 바이오의약들을 개발하고 있습니다.파킨슨병 치료제는 미국 자회사(FAScinate Therapeutics, Inc.)를 통해 미국 FDA 임상 2상 IND승인을 받고 임상 2상의 1단계 진입 준비 중에 있습니다. 추후 지출 예정인 파킨병 치료제의 임상시험 비용은 자회사 FAScinate Therapeutics, Inc.에 보유 중인 자체 자금을 활용할 예정입니다.다계통위축증 치료제(KM-819의 적응증 확대)는 2021년 10월 22일 국내 식약처에서 임상 2상 IND승인을 받았으며, 현재 임상 시험 시행을 준비하고 있습니다.</P>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[임상비용 세부지출 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="685" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="61"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">과제</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">세부과제명</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기간</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">KM-819</TD>
<TD ROWSPAN="4" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">다계통위축증 임상 2상(한국)</TD>
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">환자 모집, 스크리닝 78명</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.07 - 2022.10</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">1차 9개월 투여</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.11 - 2023.07</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">2차 9개월 투여</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023.09 - 2024.05</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">데이터 통계분석, CSR</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024.06 - 2024.10</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">230</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="622" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,830</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">출처) 당사 제시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">주) 다계통위축증은 KM-819(파킨슨병 치료제)물질의 적응증 확대로 개발 중인 프로젝트 입니다. </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(1) 다계통위축증 국내 임상 2상당사가 연구하고 있는 KM-819의 적응증인 다계통위축증은 비정형 파킨슨증 중 하나이며 임상적 특징으로 파킨슨증, 소뇌성운동실조증 및 자율신경기능 장애를 보이는 등 파킨슨병과 증세가 비슷하나 파킨슨병 치료제 즉 증상 완화제도 거의 효과가 없으며 병의 진행 속도가 빨라서 최고로 심각한 질환 중 하나로 분류되고 있습니다. PET 이미징 등 정밀검사를 하여 진단하며, 수명은 5년에서 6년 정도이고, 환자 수는 파킨슨병에 비해 5 ~ 10% 정도로서 대부분의 국가에서 희귀질환으로 규정되어 있습니다. 병의 원인은 alpha-synuclein이 뇌에서 신경세포를 지원하는 oligodendrocyte 라는 세포에서 축적됨에 기인하며, 그 결과로 뇌조직의 큰 손상이 오며 신경세포에도 손상이 오게 됩니다.</P>

<TABLE WIDTH="828" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="819"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="828" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[다계통위축증 치료제 국내 임상 2상 개요]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="825" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="640"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="649" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">내용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상시험의 목적</TD>
<TD WIDTH="649" HEIGHT="53">- 임상시험의 주요 목표는 MSA의 진행을 늦추는 안전하고 효과적인 치료법으로서 KM-819 연구의약물의 유효성을 확인하거나 반박하고 KM-819의 약동학을 평가하기 위함 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">임상시험 시행 방법</TD>
<TD WIDTH="649" HEIGHT="122">- 시험 대상자 수: 다계통위축증 환자 78명 - MSA 환자를 대상으로 한 무작위배정, 이중 눈가림, 위약 대조, 평행군 비교 - 스크리닝 기간 후, 대상자들은 KM-819 또는 위약을 받기 위해 1: 1 비율로 무작위 배정됨- 임상연구기간 : 임상 승인일로부터 24개월 (환자의 등록 상황 또는 투여기간 등에 따라 변동 가능) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">기대효과</TD>

<TD WIDTH="649" HEIGHT="122">
<P>- KM-819 연구의약물은 다계통 위축증의 병리적 진행악화를 늦추는 치료제로써 세포사멸을 유도하는 FAF1의 과발현을 억제하여 새로운 약리작용 방식으로 도파민 생성 뉴런을 사멸로부터 보호할 것으로 기대됨 - 본 임상시험에서는 시험군의 KM-819 복용시 임상적으로 유의미한 차이로 대조군에 비교하여 다계통 위축증의 진행속도가 늦춰지고 신경학적 평가의 결과가 개선될 것으로 기대됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 시험 기관</TD>
<TD WIDTH="649" HEIGHT="30">차의과학대학교 분당차병원</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">출처) 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P>현재 KM-819(다계통위축증 치료제)는 식품의약안전처에 임상 2상 시험 IND를 승인받았으며 국내 다계통위축증 환자를 대상으로 KM-819의 치료제로서 유효성 및 안전성 평가 목적의 임상 2상 시험을 진행하기 위하여 3,830백만원을 사용할 계획입니다. 상세 내역을 살펴보면, 국내 다계통위축증 환자 78명 모집 800백만원, 약 9개월의 1차 투여에 필요한 약물 생산 비용 등 1,400백만원, 약 9개월의 2차 투여에 필요한 약물 생산 비용 등 1,400백만원, 임상 데이터 분석에 230백만원을 사용할 예정입니다. 3. 운영자금: 연구개발비용(FAF1-Exosome 항암제 개발) </P>
<P></P>

<TABLE BORDER="1" WIDTH="704" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="234"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">과제</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">세부과제명</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기간</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="243" VALIGN="MIDDLE" HEIGHT="180">FAF1-exosome 항암제(KM-1004)</TD>
<TD ROWSPAN="6" WIDTH="113" VALIGN="MIDDLE" HEIGHT="180">후보물질 개발</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">용량 최적화, 효능 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2022.04 - 2023.12</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">생산 최적화 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2022.09 - 2023.10</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">1차 독성시험 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2023.10 - 2014.10</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">GMP 생산</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2023.10 - 2024.05</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">GLP 독성 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2024.06 - 2025.07</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">임상 1상 IND 제출 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">2025.08 - 2026.12</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="641" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,026</TD>
</TR>
</TBODY>
</TABLE>
<P>당사는 2021년 10월 28일 다양한 인체 유래세포에서 압출 방식으로 CDV를 생산하는 핵심 기술을 보유하고 있는 엠디뮨과 공동연구개발 계약을 체결하였습니다. CDV(Cell-Derived Vesicle)는 세포외소포의 한 종류로 세포 간 정보 전달체 역할을 하는 엑소좀(Exosome)과 유사한 물리적ㆍ화학적 특성을 보이며, 저분자 화합물을 포함한 다양한 유전자 물질을 탑재할 수 있는 신개념 약물 전달 시스템입니다. </P>
<P></P>
<P>당사는 엠디뮨과 공동연구개발을 통해 FAF1을 엑소좀에 탑재해 암세포 및 생쥐의 암 조직에 전달했을 때 다양한 종류의 종양에서 종양 크기가 감소되는 효과를 확인하였고, FAF1을 항암제로 개발하려는 논거에 대한 동물 실험에서의 개념 입증(proof of concept)을 마쳤습니다. FAF1은 암세포의 세포 분열을 억제하고, 세포 죽음을 유발할 뿐 아니라, 암 전이를 억제하는 강력한 종양 억제 인자입니다. 여러 종류의 암환자 조직에서 FAF1의 발현이 저하된다는 데이터가 있어 높은 임상적 연관성을 가지고 있는 특징이 있습니다.</P>
<P>당사는 해당 약물을 더욱 개발하여 FAF1-Exosome 항암제의 효능조건과 생산의 최적화를 이루고, 더 나아가 전임상에서 GMP 생산과 GLP 독성을 완수하여 임상 진입으로 나아갈 계획입니다.상세 내역을 살펴보면, FAF-Exosome 항암제에 대한 용량 최적화와 효능 검사를 위해 600백만원, 생산 최적화 과정에서 소요되는 비용 700백만원, 1차 독성시험 진행 비용 600백만원, 임상 1상을 위해 GMP 시설에서 약물 생산에 1,200백만원, GLP 독성 시험 1,500백만원, 임상 1상 IND 제출에 소요되는 비용 426백만원을 사용할 예정입니다. </P>
<P>3. 자금의 운용계획당사가 금번 유상증자를 통해 조달한 자금 중 일부 자금은 조달시기와 사용시기가 다소 차이가 있을 수 있습니다. 이에 조달로부터 사용시까지 미사용 자금에 대해서는 자금 사용시점 및 금리에 따라 적격 금융기관의 수시입출금 예금, 정기예금 등 금융상품으로 운용할 예정입니다.</P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-7-0">Ⅶ. 신주인수권증서 발행내역</TITLE>
<P></P>

<LIBRARY>
<TABLE-GROUP ACLASS="SUBR_PUB" ADELETETABLE="N">
<TITLE ATOC="N">신주인수권증서 발행내역</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="552" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="235"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="244" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="550" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청구일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행시기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청구자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행회사와의 관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUNIT="DMND_DT" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACODE="PUB_PRD">2022년 09월 06일</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACODE="DMNDER">한국예탁결제원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ST_CNT">5,594,048</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="466" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ST_TOT">5,594,048</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 총 모집주식수 5,600,000주(단수주 5,952주)</P>
<P></P>

<TABLE-GROUP ACLASS="SUBR_SUB" ADELETETABLE="N">
<TITLE ATOC="N">신주인수권증서에 의한 청약내역</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="535" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="218"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="227" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="534" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청약일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청약자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행회사와의 관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SUB_DT" AUNITVALUE="20220906">2022년 09월 06일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="53" ACODE="SBER">한국예탁결제원(신주인수권증서 청약)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="53" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACODE="ST_CNT">4,625,522</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SUB_DT" AUNITVALUE="20220906">2022년 09월 06일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="53" ACODE="SBER">한국예탁결제원(신주인수권증서 청약)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="53" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACODE="ST_CNT">722,323</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="450" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ST_TOT">5,347,845</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-8-0">Ⅷ. 실권주 처리내역</TITLE>
<P></P>
<P>1. 신주인수권증서 청약 실권주 및 단수주</P>

<TABLE WIDTH="602" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>신주인수권증서 청약 실권주</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구주주 배정 단수주</P>
</TD>

<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>실권주 및 단수주 총계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">246,203</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,952</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">252,155</TD>
</TR>
</TBODY>
</TABLE>
<P>2. 신주인수권증서 청약 실권주 및 단수주 처리 내역 : 초과청약 배정</P>

<TABLE WIDTH="678" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="669"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="678" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="677" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="272"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>신주인수권증서 청약실권주 및 단수주</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>초과청약주식수</P>
</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>초과청약배정비율</P>
</TD>

<TD WIDTH="281" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,625,522</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">722,323</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">100%</TD>
<TD WIDTH="281" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">초과청약 배정 후 실권주 252,155주는 일반공모 청약 진행</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>3. 초과청약 배정 후 실권주 및 단수주 처리 내역(실권주 일반공모)</P>

<TABLE WIDTH="604" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="604" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위: 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="243"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">실권주 일반공모 주식수</TD>
<TD WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">실권주 일반공모 청약주식수</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">청약 경쟁률</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">252,155</TD>
<TD WIDTH="252" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">117,009,465</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">464.04</TD>
</TR>
</TBODY>
</TABLE>
</SECTION-2>
</LIBRARY>

</SECTION-1>
</BODY>
</DOCUMENT>